The Eagon 2 fully automated fusion instrument for fused bead sample preparation is suitable for users of X-ray fluorescence spectrometry.

[ ... ]

The Axio Imager 2 has 10 stand versions and is suitable for advanced routine to high-end research in the life and materials sciences.

[ ... ]

Industrial Research Ltd’s  What’s Your Problem New Zealand? competition has been won by Resene. The company wants to develop waterborne paints made from sustainable ingredients.

[ ... ]

A gene that may play a role in the development of type 1 diabetes has been identified.

[ ... ]

The compact IRAffinity-1 FTIR spectrometer features a small footprint and a high signal-to-noise (S/N) ratio.

[ ... ]

The Geotech G100 incubator CO₂ analyser is an easy-to-use, handheld CO₂ analyser accurate in the 0-20% range with a bright, clear display.

[ ... ]

The 'What's Your Problem New Zealand?' competition gives New Zealand enterprises, big or small, the chance to win up to $1 million in research and development services from one of New Zealand’s leading technology partners.

[ ... ]

The Food & Drug Administration (FDA) has approved Roche Diagnostic’s HIV-1 test for diagnostic use in the United States. The accurate Cobas AmpliPrep/Cobas TaqMan HIV-1 test is the first fully automated HIV-1 diagnostic tool using real-time PCR technology in the US. It provides a broader range of viral load data than earlier generation tests, quantifying the amount of virus in the blood from very high to very low levels. With the test, laboratories can deliver highly accurate results faster – a decisive advantage for doctors monitoring how well a chosen therapy is working for the patient.

[ ... ]

Genetic variants in mitochondria, energy-producing structures harbouring DNA that are inherited only from the mother, are directly linked to metabolic markers for type 2 diabetes, according to a report published online recently in Genome Research.

[ ... ]

Researchers have identified the specific portion of insulin that the immune system targets in type 1 diabetes, providing a potential pathway to improved treatments for the condition.

[ ... ]

Mesoblast (ASX:MSB) revealed its MPCs were able to improve glycaemic control during a phase II trial in type 2 diabetes. [ ... ]

Novogen (ASX:NRT) and its CanTx JV have published preclinical data supporting the potential of Trx-1, injected into the peritoneal cavity, as a first-line therapy for ovarian cancer. [ ... ]

Bell Potter Securities has maintained its 'buy' rating for Mesoblast shares - with a slightly reduced price target - on the strength of the company's 1H14 results. [ ... ]

Nobel laureate Dr James D Watson has released a new hypothesis on the causation of type 2 diabetes. [ ... ]

Admedus (ASX:AHX) has announced interim study results on its phase 1 trial of a therapeutic vaccine for herpes simplex virus (HSV-2). [ ... ]

Research at Southern Cross University (SCU) has found that a popular sports supplement may help in the fight against type 2 diabetes. [ ... ]

The planet is warming, but Dr Marilyn Ball’s research group has found that rising carbon dioxide in the atmosphere makes cold-tolerant plants more susceptible to frost. [ ... ]

Big picture view of the virus's genome uncovers structures that affection function. [ ... ]

Scientists have discovered a gene that appears to regulate muscle development and size. Tweaking it could help treat Type 2 diabetes. [ ... ]

The first patients have begun treatment in Bionomics' Phase 1 trial of its vascular disruption agent. [ ... ]

Could lead to a new method of screening for this and other cancers [ ... ]

The health and medical research community has reacted positively to a draft discussion paper released today by the Strategic Review of Health and Medical Research in Australia, better known as the McKeon Review. [ ... ]

An annotated DNA sequence for human chromosome 1 was published in Nature in May. Graeme O'Neill takes a time-travelling tour of the big one. [ ... ]

BioDiem (ASX:BDM) will collaborate with Griffith University's Institute of Glycomics to explore increasing the solubility of antimicrobial compound BDM-1. [ ... ]

Federal innovation minister Kim Carr has affirmed that the government will seek to have its new R&D Tax Credit apply retrospectively from July 1 this year. [ ... ]

The Government of South Australia has announced it will fund a new $1 million initiative over three years to help South Australia’s three main universities seek patent protection for their intellectual property (IP). [ ... ]

Scientists from Sydney’s Garvan Institute have demonstrated that the drug candidate Lisofylline may be useful in the treatment of Type 2 diabetes. [ ... ]

Cancer is an evolutionary throwback, resembling early multicellular life, and flourishes when the more evolutionarily recent genes that regulate cellular cooperation fail. [ ... ]

CSL (ASX:CSL) grew its FY12 net profit 4.5% to $983 million, despite taking a significant hit on exchange rates. [ ... ]

Optiscan recruiting distributors in US, Europe and Asia for microscopes [ ... ]